SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+10.36%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$378M
AUM Growth
+$378M
(-16%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-29.34%
Top 10 Holdings %
Top 10 Hldgs %
64.24%
Holding
31
New
1
Increased
8
Reduced
16
Closed
5
Top Buys
| 1 |
Baxter International
BAX
|
$3.26M |
| 2 |
Cardinal Health
CAH
|
$2.99M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.66M |
| 4 |
MDCO
Medicines Co
MDCO
|
$1.77M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$1.73M |
Top Sells
| 1 |
HSP
HOSPIRA INC
HSP
|
$17.4M |
| 2 |
Viatris
VTRS
|
$14.5M |
| 3 |
PDCO
Patterson Companies, Inc.
PDCO
|
$11.4M |
| 4 |
Boston Scientific
BSX
|
$10.2M |
| 5 |
Quest Diagnostics
DGX
|
$9.22M |
Sector Composition
| 1 | Healthcare | 89.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $43.9M | 11.62% |
641,500
+47,600
| +8% | +$3.26M |
|
|
2
Boston Scientific
BSX
$156B
| $37.6M | 9.94% |
2,117,600
-575,000
| -21% | -$10.2M |
|
3
Eli Lilly
LLY
$657B
| $33.9M | 8.96% |
466,447
-82,000
| -15% | -$5.96M |
|
4
Stryker
SYK
$150B
| $23M | 6.07% |
248,883
-800
| -0.3% | -$73.8K |
|
5
Revvity
RVTY
$10.5B
| $21.5M | 5.68% |
420,260
-9,500
| -2% | -$486K |
|
6
Ironwood Pharmaceuticals
IRWD
$214M
| $18.6M | 4.92% |
1,162,191
+17,000
| +1% | +$272K |
|
|
7
Cardinal Health
CAH
$35.5B
| $18M | 4.77% |
199,800
+33,100
| +20% | +$2.99M |
|
8
Bristol-Myers Squibb
BMY
$96B
| $17.8M | 4.7% |
275,900
-109,300
| -28% | -$7.05M |
|
9
Edwards Lifesciences
EW
$47.8B
| $15.7M | 4.16% |
110,500
-50,700
| -31% | -$7.22M |
|
10
Tenet Healthcare
THC
$16.3B
| $12.9M | 3.42% |
261,500
+4,000
| +2% | +$198K |
|
11
Bio-Rad Laboratories Class A
BIO
$8.06B
| $12.5M | 3.3% |
92,400
-3,800
| -4% | -$514K |
|
12
Cigna
CI
$80.3B
| $12.3M | 3.26% |
95,200
+1,200
| +1% | +$155K |
|
|
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
| $11.9M | 3.16% |
130,545
-4,200
| -3% | -$384K |
|
|
14
Teva Pharmaceuticals
TEVA
$21.1B
| $11.5M | 3.03% |
184,000
+27,700
| +18% | +$1.73M |
|
15
Integra LifeSciences
IART
$1.18B
| $11.4M | 3.01% |
184,963
+21,800
| +13% | +$1.34M |
|
|
THOR
16
DELISTED
THORATEC CORPORATION
THOR
| $10.5M | 2.76% |
249,500
-143,000
| -36% | -$5.99M |
|
|
MDCO
17
DELISTED
Medicines Co
MDCO
| $9.15M | 2.42% |
326,650
+63,200
| +24% | +$1.77M |
|
|
18
Quest Diagnostics
DGX
$20.3B
| $8.81M | 2.33% |
114,628
-120,000
| -51% | -$9.22M |
|
|
LPNT
19
DELISTED
LifePoint Health, Inc.
LPNT
| $8.79M | 2.32% |
119,698
-103,202
| -46% | -$7.58M |
|
20
Vertex Pharmaceuticals
VRTX
$100B
| $8.78M | 2.32% |
74,463
-28,000
| -27% | -$3.3M |
|
21
Masimo
MASI
$7.59B
| $8.72M | 2.31% |
264,423
-17,000
| -6% | -$561K |
|
|
RAD
22
DELISTED
Rite Aid Corporation
RAD
| $6.74M | 1.78% |
776,000
-385,000
| -33% | -$3.35M |
|
23
Community Health Systems
CYH
$387M
| $5.95M | 1.57% |
113,800
-18,300
| -14% | -$957K |
|
24
Cencora
COR
$56.5B
| $5.15M | 1.36% |
45,300
-67,200
| -60% | -$7.64M |
|
|
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.66M | 0.7% |
+175,100
| New | +$2.66M |
|